Laurion Capital Management’s Gilead Sciences GILD Stock Holding History

Laurion Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,000	Closed	-$4.89M	–	630
2021 Q3	$4.89M	Buy	+70,000	New	+$4.92M	0.02%	346
2020 Q1	–	Sell	-180,000	Closed	-$11.7M	–	881
2019 Q4	$11.7M	Sell	180,000 -356,800	-66%	-$23.2M	0.09%	203
2019 Q3	$34M	Buy	536,800 +108,800	+25%	+$7.11M	0.25%	92
2019 Q2	$28.9M	Buy	+428,000	New	+$28.2M	0.28%	83
2019 Q1	–	Sell	-280,800	Closed	-$17.6M	–	1007
2018 Q4	$17.6M	Sell	280,800 -35,200	-11%	-$2.46M	0.31%	72
2018 Q3	$24.4M	Buy	316,000 +54,500	+21%	+$4.12M	0.24%	78
2018 Q2	$18.5M	Hold	261,500	–	–	0.15%	139
2018 Q1	$19.7M	Sell	261,500 -177,500	-40%	-$14.1M	0.16%	140
2017 Q4	$31.5M	Hold	439,000	–	–	0.16%	143
2017 Q3	$35.6M	Sell	439,000 -42,300	-9%	-$3.23M	0.16%	110
2017 Q2	$34.1M	Buy	481,300 +97,600	+25%	+$6.49M	0.19%	106
2017 Q1	$26.1M	Buy	+383,700	New	+$27M	0.2%	131
2016 Q4	–	Sell	-78,800	Closed	-$6.23M	–	1169
2016 Q3	$6.23M	Buy	+78,800	New	+$6.4M	0.06%	298
2013 Q4	–	Sell	-14,100	Closed	-$886K	–	233
2013 Q3	$886K	Buy	+14,100	New	+$843K	0.07%	118

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Laurion Capital Management's GILD Position: Q1 2026 in Review

Laurion Capital Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 17,812 shares worth $2.48M. The stake represents 0.11% of the portfolio and ranks #190 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in GILD as recently as Q3 2025.

Laurion Capital Management first reported a position in GILD in Q4 2015 and has held it in 23 quarters since. The position peaked at $18.7M in Q1 2016. 2,314 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Laurion Capital Management held 17,812 shares of Gilead Sciences worth $2.48M as of Q1 2026.
Gilead Sciences was a new Laurion Capital Management position in Q1 2026.
Gilead Sciences made up 0.11% of Laurion Capital Management's portfolio in Q1 2026, its #190 holding.
Laurion Capital Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 23 quarters since.
Laurion Capital Management's Gilead Sciences position peaked at $18.7M in Q1 2016.
2,314 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.